197 related articles for article (PubMed ID: 27173011)
1. Comparison of the Predictive Value of GlycA and Other Biomarkers of Inflammation for Total Death, Incident Cardiovascular Events, Noncardiovascular and Noncancer Inflammatory-Related Events, and Total Cancer Events.
Duprez DA; Otvos J; Sanchez OA; Mackey RH; Tracy R; Jacobs DR
Clin Chem; 2016 Jul; 62(7):1020-31. PubMed ID: 27173011
[TBL] [Abstract][Full Text] [Related]
2. Collagen Turnover Markers in Relation to Future Cardiovascular and Noncardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis.
Duprez DA; Gross MD; Sanchez OA; Kizer JR; Ix JH; Lima J; Tracy RP; Jacobs DR
Clin Chem; 2017 Jul; 63(7):1237-1247. PubMed ID: 28515098
[TBL] [Abstract][Full Text] [Related]
3. Associations of ideal cardiovascular health with GlycA, a novel inflammatory marker: The Multi-Ethnic Study of Atherosclerosis.
Benson EA; Tibuakuu M; Zhao D; Akinkuolie AO; Otvos JD; Duprez DA; Jacobs DR; Mora S; Michos ED
Clin Cardiol; 2018 Nov; 41(11):1439-1445. PubMed ID: 30452775
[TBL] [Abstract][Full Text] [Related]
4. GlycA, a Pro-Inflammatory Glycoprotein Biomarker, and Incident Cardiovascular Disease: Relationship with C-Reactive Protein and Renal Function.
Gruppen EG; Riphagen IJ; Connelly MA; Otvos JD; Bakker SJ; Dullaart RP
PLoS One; 2015; 10(9):e0139057. PubMed ID: 26398105
[TBL] [Abstract][Full Text] [Related]
5. Association Between Smoking and Serum GlycA and High-Sensitivity C-Reactive Protein Levels: The Multi-Ethnic Study of Atherosclerosis (MESA) and Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
Kianoush S; Bittencourt MS; Lotufo PA; Bensenor IM; Jones SR; DeFilippis AP; Toth PP; Otvos JD; Tibuakuu M; Hall ME; Harada PHN; Blaha MJ
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28838917
[TBL] [Abstract][Full Text] [Related]
6. High-Density Lipoprotein Subclasses and Noncardiovascular, Noncancer Chronic Inflammatory-Related Events Versus Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis.
Duprez DA; Otvos J; Tracy RP; Feingold KR; Greenland P; Gross MD; Lima JA; Mackey RH; Neaton JD; Sanchez OA; Jacobs DR
J Am Heart Assoc; 2015 Sep; 4(9):e002295. PubMed ID: 26370448
[TBL] [Abstract][Full Text] [Related]
7. GlycA: A Composite Nuclear Magnetic Resonance Biomarker of Systemic Inflammation.
Otvos JD; Shalaurova I; Wolak-Dinsmore J; Connelly MA; Mackey RH; Stein JH; Tracy RP
Clin Chem; 2015 May; 61(5):714-23. PubMed ID: 25779987
[TBL] [Abstract][Full Text] [Related]
8. A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls.
Bartlett DB; Connelly MA; AbouAssi H; Bateman LA; Tune KN; Huebner JL; Kraus VB; Winegar DA; Otvos JD; Kraus WE; Huffman KM
Arthritis Res Ther; 2016 Apr; 18():86. PubMed ID: 27067270
[TBL] [Abstract][Full Text] [Related]
9. Association of the Novel Inflammatory Marker GlycA and Incident Heart Failure and Its Subtypes of Preserved and Reduced Ejection Fraction: The Multi-Ethnic Study of Atherosclerosis.
Jang S; Ogunmoroti O; Ndumele CE; Zhao D; Rao VN; Fashanu OE; Tibuakuu M; Otvos JD; Benson EM; Ouyang P; Michos ED
Circ Heart Fail; 2020 Aug; 13(8):e007067. PubMed ID: 32762458
[TBL] [Abstract][Full Text] [Related]
10. The association of novel inflammatory marker GlycA and incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis (MESA).
Jang S; Ogunmoroti O; Zhao D; Fashanu OE; Tibuakuu M; Benson EM; Norby F; Otvos JD; Heckbert SR; Szklo M; Michos ED
PLoS One; 2021; 16(3):e0248644. PubMed ID: 33765041
[TBL] [Abstract][Full Text] [Related]
11. GlycA: A New Biomarker for Systemic Inflammation and Cardiovascular Disease (CVD) Risk Assessment.
Ballout RA; Remaley AT
J Lab Precis Med; 2020 Apr; 5():. PubMed ID: 32363327
[TBL] [Abstract][Full Text] [Related]
12. A novel protein glycan biomarker and future cardiovascular disease events.
Akinkuolie AO; Buring JE; Ridker PM; Mora S
J Am Heart Assoc; 2014 Sep; 3(5):e001221. PubMed ID: 25249300
[TBL] [Abstract][Full Text] [Related]
13. GlycA and hsCRP are independent and additive predictors of future cardiovascular events among patients undergoing angiography: The intermountain heart collaborative study.
Muhlestein JB; May HT; Galenko O; Knowlton KU; Otvos JD; Connelly MA; Lappe DL; Anderson JL
Am Heart J; 2018 Aug; 202():27-32. PubMed ID: 29803983
[TBL] [Abstract][Full Text] [Related]
14. GlycA, a marker of acute phase glycoproteins, and the risk of incident type 2 diabetes mellitus: PREVEND study.
Connelly MA; Gruppen EG; Wolak-Dinsmore J; Matyus SP; Riphagen IJ; Shalaurova I; Bakker SJ; Otvos JD; Dullaart RP
Clin Chim Acta; 2016 Jan; 452():10-7. PubMed ID: 26549655
[TBL] [Abstract][Full Text] [Related]
15. Circulating N-Linked Glycoprotein Side-Chain Biomarker, Rosuvastatin Therapy, and Incident Cardiovascular Disease: An Analysis From the JUPITER Trial.
Akinkuolie AO; Glynn RJ; Padmanabhan L; Ridker PM; Mora S
J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27413042
[TBL] [Abstract][Full Text] [Related]
16. The novel inflammatory marker GlycA and the prevalence and progression of valvular and thoracic aortic calcification: The Multi-Ethnic Study of Atherosclerosis.
Ezeigwe A; Fashanu OE; Zhao D; Budoff MJ; Otvos JD; Thomas IC; Mora S; Tibuakuu M; Michos ED
Atherosclerosis; 2019 Mar; 282():91-99. PubMed ID: 30716566
[TBL] [Abstract][Full Text] [Related]
17. Association of N-Linked Glycoprotein Acetyls and Colorectal Cancer Incidence and Mortality.
Chandler PD; Akinkuolie AO; Tobias DK; Lawler PR; Li C; Moorthy MV; Wang L; Duprez DA; Jacobs DR; Glynn RJ; Otvos J; Connelly MA; Post WS; Ridker PM; Manson JE; Buring JE; Lee IM; Mora S
PLoS One; 2016; 11(11):e0165615. PubMed ID: 27902713
[TBL] [Abstract][Full Text] [Related]
18. GlycA, a Novel Inflammatory Marker and Its Association With Peripheral Arterial Disease and Carotid Plaque: The Multi-Ethnic Study of Atherosclerosis.
Fashanu OE; Oyenuga AO; Zhao D; Tibuakuu M; Mora S; Otvos JD; Stein JH; Michos ED
Angiology; 2019 Sep; 70(8):737-746. PubMed ID: 31030528
[TBL] [Abstract][Full Text] [Related]
19. GlycA, a novel inflammatory marker, is associated with subclinical coronary disease.
Tibuakuu M; Fashanu OE; Zhao D; Otvos JD; Brown TT; Haberlen SA; Guallar E; Budoff MJ; Palella FJ; Martinson JJ; Akinkuolie AO; Mora S; Post WS; Michos ED
AIDS; 2019 Mar; 33(3):547-557. PubMed ID: 30475263
[TBL] [Abstract][Full Text] [Related]
20. Composite acute phase glycoproteins with coronary artery calcification depends on metabolic syndrome presence - The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
Harada PH; Benseñor IM; Bittencourt MS; Nasir K; Blaha MJ; Jones SR; Toth PP; Lotufo PA
J Cardiol; 2019 May; 73(5):408-415. PubMed ID: 30595405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
